BCL2L12A localizes to the cell nucleus and induces growth inhibition through G2/M arrest in CHO cells.
BCL2L12, a newly identified member of Bcl-2 family, and its transcript variant BCL2L12A have been found to be associated with favorable prognosis in breast cancer patients while correlated with tumorigenesis of glioblastoma and colon cancer. However, the biological functions of BCL2L12 and especially those of BCL2L12A are largely unknown. Here, we report that, unlike other Bcl-2 family proteins, BCL2L12 and its transcript variant BCL2L12A are nuclear proteins. Interestingly, BCL2L12 forms speckle patterns in the nuclei and potently induces apoptosis in CHO cells. BCL2L12A had a diffuse distribution in the nuclei and inhibits cell growth by inducing cell cycle arrested at G2/M transition in CHO cells. More importantly, BCL2L12A-induced G2/M arrest was associated with a slight up-regulation of cyclin B1 and significant down-regulation of an active form of cyclin B1 phosphorylated at Ser147. Taken together, our study suggests that both BCL2L12 and BCL2L12A have negative effects on CHO cell growths, and that BCL2L12A is a potential cell cycle regulator that interferes with G2-M transition.
Hong
Yi
Y
Gene Research Center, Shanghai Medical College, Fudan University, 200032 Shanghai, People's Republic of China.
Yang
Junwu
J
Chi
Yayun
Y
Wang
Wenzong
W
Wu
Weibing
W
Yun
Xiaojing
X
Kong
Xiangfei
X
Gu
Jianxin
J
D021581:Active Transport, Cell Nucleus; D000818:Animals; D016466:CHO Cells; D002455:Cell Division; D006224:Cricetinae; D003412:Cricetulus; D016195:G2 Phase; D006367:HeLa Cells; D006801:Humans; D009687:Nuclear Proteins; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics / Q000378:metabolism*; D014162:Transfection
C431152:BCL2L13 protein, human; D009687:Nuclear Proteins; D019253:Proto-Oncogene Proteins c-bcl-2